Association of envelope-specific B-cell differentiation and viral selective pressure signatures in HIV-1 CRF01_AE infection
In HIV type 1 (HIV-1) infection, virus-specific B-cell and neutralizing antibody (NAb) responses are impaired but exert selective pressure on target viral Envelope (Env) resulting in prominent sequence diversification among geographical areas. The basal induction patterns of HIV Env-specific B cells...
Saved in:
Published in | AIDS (London) Vol. 36; no. 12; pp. 1629 - 1641 |
---|---|
Main Authors | , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
Lippincott Williams & Wilkins
01.10.2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | In HIV type 1 (HIV-1) infection, virus-specific B-cell and neutralizing antibody (NAb) responses are impaired but exert selective pressure on target viral Envelope (Env) resulting in prominent sequence diversification among geographical areas. The basal induction patterns of HIV Env-specific B cells and their interaction with HIV Env awaits clarification.
We investigated the relationship of Env polymorphisms and Env-specific B-cell responses in treatment-naive HIV-1 CRF01_AE-infected Vietnamese.
Samples of 43 HIV-1 CRF01_AE infection-identified individuals were divided into acute-phase ( n = 12) and chronic-phase ( n = 31) by combined criteria of serological recent-infection assay and clinical parameters. We quantified subcloning-based polymorphic residue site numbers in plasma-derived Env variable region 1-5 (V1-V5)-coding regions within each individual, designating their summation within each region as variant index. Peripheral blood Env gp 140-specific B-cell responses and plasma neutralizing activity of Env pseudoviruses were examined to analyze their relationship with variant index.
HIV-1 CRF01_AE Env gp140-specific total B-cell and plasma cell (CD19 + IgD - CD27 + CD38 + CD138 + ) responses were determined. In chronic-phase samples, significant correlation of variant index in all Env V1-V5 regions with Env-specific plasma cell responses was shown, and V1-V5 total variant index correlated stronger with Env-specific plasma cell as compared with total Env-specific B-cell responses. Env V5 variant index was significantly higher in chronic-phase cross-neutralizers of V5-polymorphic/VRC01-insensitive CRF01_AE Env.
Results revealed the association between circulating Env-specific plasma cell responses and Env polymorphisms, implicating selective pressure on Env by plasma cell-derived antibodies and conversely suggests that Env-specific B-cell induction alone is insufficient for exerting Env selective pressure in HIV infection. |
---|---|
AbstractList | In HIV type 1 (HIV-1) infection, virus-specific B-cell and neutralizing antibody (NAb) responses are impaired but exert selective pressure on target viral Envelope (Env) resulting in prominent sequence diversification among geographical areas. The basal induction patterns of HIV Env-specific B cells and their interaction with HIV Env awaits clarification.
We investigated the relationship of Env polymorphisms and Env-specific B-cell responses in treatment-naive HIV-1 CRF01_AE-infected Vietnamese.
Samples of 43 HIV-1 CRF01_AE infection-identified individuals were divided into acute-phase ( n = 12) and chronic-phase ( n = 31) by combined criteria of serological recent-infection assay and clinical parameters. We quantified subcloning-based polymorphic residue site numbers in plasma-derived Env variable region 1-5 (V1-V5)-coding regions within each individual, designating their summation within each region as variant index. Peripheral blood Env gp 140-specific B-cell responses and plasma neutralizing activity of Env pseudoviruses were examined to analyze their relationship with variant index.
HIV-1 CRF01_AE Env gp140-specific total B-cell and plasma cell (CD19 + IgD - CD27 + CD38 + CD138 + ) responses were determined. In chronic-phase samples, significant correlation of variant index in all Env V1-V5 regions with Env-specific plasma cell responses was shown, and V1-V5 total variant index correlated stronger with Env-specific plasma cell as compared with total Env-specific B-cell responses. Env V5 variant index was significantly higher in chronic-phase cross-neutralizers of V5-polymorphic/VRC01-insensitive CRF01_AE Env.
Results revealed the association between circulating Env-specific plasma cell responses and Env polymorphisms, implicating selective pressure on Env by plasma cell-derived antibodies and conversely suggests that Env-specific B-cell induction alone is insufficient for exerting Env selective pressure in HIV infection. In HIV type 1 (HIV-1) infection, virus-specific B-cell and neutralizing antibody (NAb) responses are impaired but exert selective pressure on target viral Envelope (Env) resulting in prominent sequence diversification among geographical areas. The basal induction patterns of HIV Env-specific B cells and their interaction with HIV Env awaits clarification.OBJECTIVEIn HIV type 1 (HIV-1) infection, virus-specific B-cell and neutralizing antibody (NAb) responses are impaired but exert selective pressure on target viral Envelope (Env) resulting in prominent sequence diversification among geographical areas. The basal induction patterns of HIV Env-specific B cells and their interaction with HIV Env awaits clarification.We investigated the relationship of Env polymorphisms and Env-specific B-cell responses in treatment-naive HIV-1 CRF01_AE-infected Vietnamese.DESIGNWe investigated the relationship of Env polymorphisms and Env-specific B-cell responses in treatment-naive HIV-1 CRF01_AE-infected Vietnamese.Samples of 43 HIV-1 CRF01_AE infection-identified individuals were divided into acute-phase ( n = 12) and chronic-phase ( n = 31) by combined criteria of serological recent-infection assay and clinical parameters. We quantified subcloning-based polymorphic residue site numbers in plasma-derived Env variable region 1-5 (V1-V5)-coding regions within each individual, designating their summation within each region as variant index. Peripheral blood Env gp 140-specific B-cell responses and plasma neutralizing activity of Env pseudoviruses were examined to analyze their relationship with variant index.METHODSSamples of 43 HIV-1 CRF01_AE infection-identified individuals were divided into acute-phase ( n = 12) and chronic-phase ( n = 31) by combined criteria of serological recent-infection assay and clinical parameters. We quantified subcloning-based polymorphic residue site numbers in plasma-derived Env variable region 1-5 (V1-V5)-coding regions within each individual, designating their summation within each region as variant index. Peripheral blood Env gp 140-specific B-cell responses and plasma neutralizing activity of Env pseudoviruses were examined to analyze their relationship with variant index.HIV-1 CRF01_AE Env gp140-specific total B-cell and plasma cell (CD19 + IgD - CD27 + CD38 + CD138 + ) responses were determined. In chronic-phase samples, significant correlation of variant index in all Env V1-V5 regions with Env-specific plasma cell responses was shown, and V1-V5 total variant index correlated stronger with Env-specific plasma cell as compared with total Env-specific B-cell responses. Env V5 variant index was significantly higher in chronic-phase cross-neutralizers of V5-polymorphic/VRC01-insensitive CRF01_AE Env.RESULTSHIV-1 CRF01_AE Env gp140-specific total B-cell and plasma cell (CD19 + IgD - CD27 + CD38 + CD138 + ) responses were determined. In chronic-phase samples, significant correlation of variant index in all Env V1-V5 regions with Env-specific plasma cell responses was shown, and V1-V5 total variant index correlated stronger with Env-specific plasma cell as compared with total Env-specific B-cell responses. Env V5 variant index was significantly higher in chronic-phase cross-neutralizers of V5-polymorphic/VRC01-insensitive CRF01_AE Env.Results revealed the association between circulating Env-specific plasma cell responses and Env polymorphisms, implicating selective pressure on Env by plasma cell-derived antibodies and conversely suggests that Env-specific B-cell induction alone is insufficient for exerting Env selective pressure in HIV infection.CONCLUSIONResults revealed the association between circulating Env-specific plasma cell responses and Env polymorphisms, implicating selective pressure on Env by plasma cell-derived antibodies and conversely suggests that Env-specific B-cell induction alone is insufficient for exerting Env selective pressure in HIV infection. |
Author | Kanno, Yoshiaki Harada, Shigeyoshi Hau, Trang Thi Thu Kawana-Tachikawa, Ai Matano, Tetsuro Nishizawa, Masako Phan, My Ha Matsuoka, Saori Hall, William W. Yamamoto, Hiroyuki Nomura, Takushi Nguyen, Lan Anh Thi |
AuthorAffiliation | AIDS Research Center, National Institute of Infectious Diseases Centre for Bio-Medical Research, National Institute of Hygiene and Epidemiology, Hanoi, Vietnam |
AuthorAffiliation_xml | – name: Centre for Bio-Medical Research, National Institute of Hygiene and Epidemiology, Hanoi, Vietnam – name: AIDS Research Center, National Institute of Infectious Diseases |
Author_xml | – sequence: 1 givenname: Trang Thi Thu surname: Hau fullname: Hau, Trang Thi Thu organization: AIDS Research Center, National Institute of Infectious Diseases – sequence: 2 givenname: Masako surname: Nishizawa fullname: Nishizawa, Masako organization: AIDS Research Center, National Institute of Infectious Diseases – sequence: 3 givenname: Shigeyoshi surname: Harada fullname: Harada, Shigeyoshi organization: AIDS Research Center, National Institute of Infectious Diseases – sequence: 4 givenname: My Ha surname: Phan fullname: Phan, My Ha organization: Centre for Bio-Medical Research, National Institute of Hygiene and Epidemiology, Hanoi, Vietnam – sequence: 5 givenname: Yoshiaki surname: Kanno fullname: Kanno, Yoshiaki organization: AIDS Research Center, National Institute of Infectious Diseases – sequence: 6 givenname: Takushi surname: Nomura fullname: Nomura, Takushi organization: AIDS Research Center, National Institute of Infectious Diseases – sequence: 7 givenname: Saori surname: Matsuoka fullname: Matsuoka, Saori organization: AIDS Research Center, National Institute of Infectious Diseases – sequence: 8 givenname: Ai surname: Kawana-Tachikawa fullname: Kawana-Tachikawa, Ai organization: AIDS Research Center, National Institute of Infectious Diseases – sequence: 9 givenname: William W. surname: Hall fullname: Hall, William W. organization: Centre for Bio-Medical Research, National Institute of Hygiene and Epidemiology, Hanoi, Vietnam – sequence: 10 givenname: Tetsuro surname: Matano fullname: Matano, Tetsuro organization: AIDS Research Center, National Institute of Infectious Diseases – sequence: 11 givenname: Lan Anh Thi surname: Nguyen fullname: Nguyen, Lan Anh Thi organization: Centre for Bio-Medical Research, National Institute of Hygiene and Epidemiology, Hanoi, Vietnam – sequence: 12 givenname: Hiroyuki surname: Yamamoto fullname: Yamamoto, Hiroyuki organization: AIDS Research Center, National Institute of Infectious Diseases |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/35848590$$D View this record in MEDLINE/PubMed |
BookMark | eNqNkUFv1DAQhS3Uim5b_gFCPnJxO46TOOG2LC2tVKkCUa6W44ypwWsHO9kK8efJdrdS1RNzmdHoeyPNe8fkIMSAhLzlcMahledflp_O4FkJUYhXZMFLKVhVSX5AFlDULWuFhCNynPPPGaqgaV6TI1E1ZVO1sCB_lzlH4_ToYqDRUgwb9HFAlgc0zjpDPzKD3tPeWYsJw7hndejpxiXtaUaPZnQbpEPCnKeENLsfQY_zlKkL9Or6O-N09fUSuFpezBu75WM4JYdW-4xv9v2E3F1efFtdsZvbz9er5Q0zJW8Ea3spu7qVBirRdsbUCNBYsGVnuJaSY1dJa0ppmkLWHZel6Ctdl21ttaxQ9OKEvN_dHVL8PWEe1drl7VM6YJyyml3iZQ1SwIy-26NTt8ZeDcmtdfqjngybgQ87wKSYc0KrjBsfHRmTdl5xUNt01JyOepnOLC5fiJ_u_5_sIfoRU_7lpwdM6h61H-8f8QIEsAKKggNwYDvlPwBcoNk |
CitedBy_id | crossref_primary_10_7554_eLife_88849_4 crossref_primary_10_7554_eLife_88849 |
Cites_doi | 10.1111/imr.12508 10.1038/ni1281 10.1089/aid.2019.0179 10.1038/nm1520 10.1371/journal.ppat.1005369 10.1038/nature12746 10.1128/JVI.00557-16 10.1016/j.micinf.2018.10.001 10.1371/journal.ppat.1007819 10.1371/journal.pone.0189999 10.1371/journal.pone.0026244 10.1016/j.bbrc.2018.11.063 10.1038/mi.2014.69 10.1038/nature07746 10.1097/QAD.0000000000003013 10.1371/journal.ppat.1003738 10.7448/IAS.17.1.19053 10.1371/journal.pone.0024078 10.1038/nature01470 10.1038/nature12744 10.1016/j.meegid.2011.04.034 10.1128/JVI.03608-14 10.1186/1742-4690-9-22 10.1038/nature07930 10.1128/JVI.00828-17 10.1128/JVI.75.22.10892-10905.2001 10.1371/journal.pmed.1000107 10.1038/nm.2985 10.1038/nature21435 10.1128/JVI.72.1.164-169.1998 10.1097/QAD.0b013e328342ff93 10.1089/088922203322493111 10.1097/QAD.0000000000001906 10.1016/j.path.2015.09.009 10.1056/NEJMoa0908492 10.1016/j.virol.2009.11.003 10.1038/nature12053 10.1016/j.vaccine.2018.10.084 10.4049/jimmunol.0901068 10.1099/jgv.0.001198 10.1089/aid.2005.21.586 10.1128/jvi.67.11.6642-6647.1993 10.1016/j.cell.2014.06.022 10.1073/pnas.181347898 10.1084/jem.20032236 10.1038/31405 10.1089/aid.1998.14.1687 10.1097/QAD.0000000000002620 10.1097/QAD.0000000000000969 10.1038/nm1244 10.1016/j.jim.2008.11.012 10.1038/nri3795 10.1126/science.1192819 10.1182/blood-2005-11-013383 10.1371/journal.pone.0008805 10.7554/eLife.62648 10.1371/journal.pone.0114947 10.1016/j.micinf.2015.12.009 10.1126/science.1086907 10.1128/JVI.01583-08 10.1186/1742-4690-11-32 10.1007/s00705-018-4011-7 10.1089/aid.2016.0029 |
ContentType | Journal Article |
Copyright | Lippincott Williams & Wilkins Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved. |
Copyright_xml | – notice: Lippincott Williams & Wilkins – notice: Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
DOI | 10.1097/QAD.0000000000003323 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1473-5571 |
EndPage | 1641 |
ExternalDocumentID | 35848590 10_1097_QAD_0000000000003323 00002030-202210010-00003 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- .XZ .Z2 01R 0R~ 1J1 23M 2WC 354 40H 4Q1 4Q2 4Q3 5GY 5RE 5VS 71W 77Y 7O~ 85S 8L- AAAAV AAAXR AAGIX AAHPQ AAIQE AAJCS AAMOA AAMTA AAQKA AARTV AASCR AASOK AASXQ AAUEB AAXQO ABASU ABBUW ABDIG ABIVO ABJNI ABPXF ABVCZ ABXVJ ABXYN ABZAD ABZZY ACDDN ACDOF ACEWG ACGFS ACILI ACLDA ACOAL ACWDW ACWRI ACXJB ACXNZ ACZKN ADBBV ADGGA ADHPY AE3 AE6 AEBDS AENEX AFBFQ AFDTB AFEXH AFMBP AFNMH AFSOK AFUWQ AGINI AHOMT AHQNM AHQVU AHVBC AIJEX AINUH AJCLO AJIOK AJNWD AJZMW AKCTQ AKULP ALKUP ALMA_UNASSIGNED_HOLDINGS ALMTX AMJPA AMKUR AMNEI AOHHW AOQMC BAWUL BOYCO BQLVK BYPQX C45 CS3 DIK DIWNM E.X E3Z EBS EEVPB ERAAH EX3 F2K F2L F2M F2N F5P FCALG FL- GNXGY GQDEL H0~ HLJTE HZ~ IKREB IKYAY IN~ IPNFZ JK3 JK8 K8S KD2 KMI KQ8 L-C L7B N9A N~7 N~B O9- OAG OAH OBH ODMTH OHH OHYEH OK1 OL1 OLB OLG OLH OLU OLV OLY OLZ OPUJH OPX OVD OVDNE OVIDH OVLEI OVOZU OWU OWV OWW OWX OWY OWZ OXXIT P2P RIG RLZ S4R S4S SJN TEORI TR2 TSPGW V2I VVN W3M WOQ WOW X3V X3W XXN XYM YFH AAYXX CITATION ACIJW AWKKM CGR CUY CVF ECM EIF NPM ODA OJAPA OLW 7X8 |
ID | FETCH-LOGICAL-c4183-9d77b697c0539bcc6e008f0f4bc1a771eb57fc47c8276b1743d5a6496fa75e3d3 |
ISSN | 0269-9370 1473-5571 |
IngestDate | Thu Jul 10 23:36:37 EDT 2025 Wed Feb 19 02:24:45 EST 2025 Thu Jul 03 08:21:58 EDT 2025 Thu Apr 24 22:57:20 EDT 2025 Fri May 16 03:52:26 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 12 |
Language | English |
License | Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved. |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c4183-9d77b697c0539bcc6e008f0f4bc1a771eb57fc47c8276b1743d5a6496fa75e3d3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 35848590 |
PQID | 2691460730 |
PQPubID | 23479 |
PageCount | 13 |
ParticipantIDs | proquest_miscellaneous_2691460730 pubmed_primary_35848590 crossref_citationtrail_10_1097_QAD_0000000000003323 crossref_primary_10_1097_QAD_0000000000003323 wolterskluwer_health_00002030-202210010-00003 |
PublicationCentury | 2000 |
PublicationDate | 2022-October-1 |
PublicationDateYYYYMMDD | 2022-10-01 |
PublicationDate_xml | – month: 10 year: 2022 text: 2022-October-1 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | England |
PublicationPlace_xml | – name: England |
PublicationTitle | AIDS (London) |
PublicationTitleAlternate | AIDS |
PublicationYear | 2022 |
Publisher | Lippincott Williams & Wilkins |
Publisher_xml | – name: Lippincott Williams & Wilkins |
References | Lan (R16-20250608) 2003; 19 Cizmeci (R57-20250608) 2021; 10 Kawashima (R4-20250608) 2009; 458 Van Tran (R22-20250608) 2016; 30 Bussmann (R40-20250608) 2010; 397 Moir (R39-20250608) 2004; 200 Anthony (R10-20250608) 2017; 91 Hemelaar (R14-20250608) 2011; 25 Gao (R12-20250608) 2014; 158 Wei (R52-20250608) 2003; 422 Dhande (R55-20250608) 2020; 34 Wang (R26-20250608) 2018; 163 Wibmer (R11-20250608) 2013; 9 Bonsignori (R41-20250608) 2009; 183 Takahashi (R23-20250608) 2019; 21 Wardemann (R46-20250608) 2003; 301 Frahm (R2-20250608) 2006; 7 Kanno (R63-20250608) 2021; 35 Utachee (R24-20250608) 2014; 11 Kwong (R5-20250608) 1998; 393 Nishimura (R61-20250608) 2017; 543 Matano (R1-20250608) 1998; 72 Bontell (R29-20250608) 2012; 12 Lazaro (R21-20250608) 2011; 6 Muster (R50-20250608) 1993; 67 Titanji (R38-20250608) 2006; 108 Beretta (R44-20250608) 2018; 32 Rerks-Ngarm (R31-20250608) 2009; 361 Lynch (R36-20250608) 2015; 89 Lazaro (R20-20250608) 2005; 21 Ji (R30-20250608) 2018; 36 Sacha (R56-20250608) 2015; 8 Barouch (R60-20250608) 2013; 503 Scheid (R47-20250608) 2009; 343 Shingai (R59-20250608) 2013; 503 Li (R17-20250608) 2016; 32 Duong (R32-20250608) 2015; 10 Iseda (R62-20250608) 2016; 90 Scheid (R45-20250608) 2009; 458 Liao (R9-20250608) 2013; 496 Beyrer (R15-20250608) 1998; 14 Kelsoe (R6-20250608) 2017; 275 Mouquet (R48-20250608) 2011; 6 Levesque (R8-20250608) 2009; 6 Thida (R27-20250608) 2019; 508 Trkola (R58-20250608) 2005; 11 Doria-Rose (R54-20250608) 2009; 83 Olteanu (R34-20250608) 2016; 9 Chaitaveep (R25-20250608) 2016; 18 Nutt (R33-20250608) 2015; 15 Zhou (R35-20250608) 2010; 329 Kiepiela (R3-20250608) 2007; 13 Kraft (R42-20250608) 2012; 9 Moir (R7-20250608) 2001; 98 Jiamsakul (R28-20250608) 2014; 17 Moore (R13-20250608) 2012; 18 Chen (R18-20250608) 2019; 100 Corti (R49-20250608) 2010; 5 Sasaki (R19-20250608) 2020; 36 Zwick (R51-20250608) 2001; 75 Landais (R53-20250608) 2016; 12 Kafando (R43-20250608) 2017; 12 Zhou (R37-20250608) 2019; 15 |
References_xml | – volume: 275 start-page: 79 year: 2017 ident: R6-20250608 article-title: Host controls of HIV broadly neutralizing antibody development publication-title: Immunol Rev doi: 10.1111/imr.12508 – volume: 7 start-page: 173 year: 2006 ident: R2-20250608 article-title: Control of human immunodeficiency virus replication by cytotoxic T lymphocytes targeting subdominant epitopes publication-title: Nat Immunol doi: 10.1038/ni1281 – volume: 36 start-page: 242 year: 2020 ident: R19-20250608 article-title: Characterization of HIV-1 CRF01_AE env genes derived from recently infected Indonesian individuals publication-title: AIDS Res Hum Retroviruses doi: 10.1089/aid.2019.0179 – volume: 13 start-page: 46 year: 2007 ident: R3-20250608 article-title: CD8+ T-cell responses to different HIV proteins have discordant associations with viral load publication-title: Nat Med doi: 10.1038/nm1520 – volume: 12 start-page: e1005369 year: 2016 ident: R53-20250608 article-title: Broadly neutralizing antibody responses in a large longitudinal sub-Saharan HIV primary infection cohort publication-title: PLoS Pathog doi: 10.1371/journal.ppat.1005369 – volume: 503 start-page: 277 year: 2013 ident: R59-20250608 article-title: Antibody-mediated immunotherapy of macaques chronically infected with SHIV suppresses viraemia publication-title: Nature doi: 10.1038/nature12746 – volume: 90 start-page: 6276 year: 2016 ident: R62-20250608 article-title: Biphasic CD8 + T-cell defense in simian immunodeficiency virus control by acute-phase passive neutralizing antibody immunization publication-title: J Virol doi: 10.1128/JVI.00557-16 – volume: 21 start-page: 113 year: 2019 ident: R23-20250608 article-title: Human leukocyte antigen-associated gag and nef polymorphisms in HIV-1 subtype A/E-infected individuals in Vietnam publication-title: Microbes Infect doi: 10.1016/j.micinf.2018.10.001 – volume: 15 start-page: e1007819 year: 2019 ident: R37-20250608 article-title: Broadly resistant HIV-1 against CD4-binding site neutralizing antibodies publication-title: PLoS Pathog doi: 10.1371/journal.ppat.1007819 – volume: 12 start-page: e0189999 year: 2017 ident: R43-20250608 article-title: HIV-1 envelope sequence-based diversity measures for identifying recent infections publication-title: PLoS One doi: 10.1371/journal.pone.0189999 – volume: 6 start-page: e26244 year: 2011 ident: R21-20250608 article-title: Molecular characterization of HIV-1 CRF01_AE in mekong delta, vietnam, and impact of T-cell epitope mutations on HLA recognition (ANRS 12159) publication-title: PLoS One doi: 10.1371/journal.pone.0026244 – volume: 508 start-page: 46 year: 2019 ident: R27-20250608 article-title: The role of conventional antibodies targeting the CD4 binding site and CD4-induced epitopes in the control of HIV-1 CRF01_AE viruses publication-title: Biochem Biophys Res Commun doi: 10.1016/j.bbrc.2018.11.063 – volume: 8 start-page: 316 year: 2015 ident: R56-20250608 article-title: Restricted isotype, distinct variable gene usage, and high rate of gp120 specificity of HIV-1 envelope-specific B cells in colostrum compared with those in blood of HIV-1-infected, lactating African women publication-title: Mucosal Immunol doi: 10.1038/mi.2014.69 – volume: 458 start-page: 641 year: 2009 ident: R4-20250608 article-title: Adaptation of HIV-1 to human leukocyte antigen class I publication-title: Nature doi: 10.1038/nature07746 – volume: 35 start-page: 2281 year: 2021 ident: R63-20250608 article-title: Late-phase dominance of a single epitope-specific CD8+ T-cell response in passive neutralizing antibody-infused SIV controllers publication-title: AIDS doi: 10.1097/QAD.0000000000003013 – volume: 9 start-page: e1003738 year: 2013 ident: R11-20250608 article-title: Viral escape from HIV-1 neutralizing antibodies drives increased plasma neutralization breadth through sequential recognition of multiple epitopes and immunotypes publication-title: PLoS Pathog doi: 10.1371/journal.ppat.1003738 – volume: 17 start-page: 19053 year: 2014 ident: R28-20250608 article-title: HIV multidrug resistance at first-line antiretroviral failure and subsequent virological response in Asia publication-title: J Int AIDS Soc doi: 10.7448/IAS.17.1.19053 – volume: 6 start-page: e24078 year: 2011 ident: R48-20250608 article-title: Memory B cell antibodies to HIV-1 gp140 cloned from individuals infected with Clade A and B viruses publication-title: PLoS One doi: 10.1371/journal.pone.0024078 – volume: 422 start-page: 307 year: 2003 ident: R52-20250608 article-title: Antibody neutralization and escape by HIV-1 publication-title: Nature doi: 10.1038/nature01470 – volume: 503 start-page: 224 year: 2013 ident: R60-20250608 article-title: Therapeutic efficacy of potent neutralizing HIV-1-specific monoclonal antibodies in SHIV-infected rhesus monkeys publication-title: Nature doi: 10.1038/nature12744 – volume: 12 start-page: 448 year: 2012 ident: R29-20250608 article-title: Transmitted drug resistance and phylogenetic analysis of HIV CRF01_AE in Northern Vietnam publication-title: Infect Genet Evol doi: 10.1016/j.meegid.2011.04.034 – volume: 89 start-page: 4201 year: 2015 ident: R36-20250608 article-title: HIV-1 fitness cost associated with escape from the VRC01 class of CD4 binding site neutralizing antibodies publication-title: J Virol doi: 10.1128/JVI.03608-14 – volume: 9 start-page: 22 year: 2012 ident: R42-20250608 article-title: Timing and source of subtype-C HIV-1 superinfection in the newly infected partner of Zambian couples with disparate viruses publication-title: Retrovirology doi: 10.1186/1742-4690-9-22 – volume: 458 start-page: 636 year: 2009 ident: R45-20250608 article-title: Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals publication-title: Nature doi: 10.1038/nature07930 – volume: 91 start-page: e00828 year: 2017 ident: R10-20250608 article-title: Cooperation between strain-specific and broadly neutralizing responses limited viral escape and prolonged the exposure of the broadly neutralizing epitope publication-title: J Virol doi: 10.1128/JVI.00828-17 – volume: 75 start-page: 10892 year: 2001 ident: R51-20250608 article-title: Broadly neutralizing antibodies targeted to the membrane-proximal external region of human immunodeficiency virus type 1 glycoprotein gp41 publication-title: J Virol doi: 10.1128/JVI.75.22.10892-10905.2001 – volume: 6 start-page: e1000107 year: 2009 ident: R8-20250608 article-title: Polyclonal B cell differentiation and loss of gastrointestinal tract germinal centers in the earliest stages of HIV-1 Infection publication-title: PLoS Med doi: 10.1371/journal.pmed.1000107 – volume: 18 start-page: 1688 year: 2012 ident: R13-20250608 article-title: Evolution of an HIV glycan-dependent broadly neutralizing antibody epitope through immune escape publication-title: Nat Med doi: 10.1038/nm.2985 – volume: 543 start-page: 559 year: 2017 ident: R61-20250608 article-title: Early antibody therapy can induce long-lasting immunity to SHIV publication-title: Nature doi: 10.1038/nature21435 – volume: 72 start-page: 164 year: 1998 ident: R1-20250608 article-title: Administration of an anti-CD8 monoclonal antibody interferes with the clearance of chimeric simian/human immunodeficiency virus during primary infections of rhesus macaques publication-title: J Virol doi: 10.1128/JVI.72.1.164-169.1998 – volume: 25 start-page: 679 year: 2011 ident: R14-20250608 article-title: Global trends in molecular epidemiology of HIV-1 during 2000–2007 publication-title: AIDS doi: 10.1097/QAD.0b013e328342ff93 – volume: 19 start-page: 925 year: 2003 ident: R16-20250608 article-title: HIV type 1 isolates from 200 untreated individuals in Ho Chi Minh City (Vietnam): ANRS 1257 Study. Large predominance of CRF01_AE and presence of major resistance mutations to antiretroviral drugs publication-title: AIDS Res Hum Retroviruses doi: 10.1089/088922203322493111 – volume: 32 start-page: 1917 year: 2018 ident: R44-20250608 article-title: Phenotypic properties of envelope glycoproteins of transmitted HIV-1 variants from patients belonging to transmission chains publication-title: AIDS doi: 10.1097/QAD.0000000000001906 – volume: 9 start-page: 101 year: 2016 ident: R34-20250608 article-title: Role of flow cytometry in the diagnosis and prognosis of plasma cell myeloma publication-title: Surg Pathol Clin doi: 10.1016/j.path.2015.09.009 – volume: 361 start-page: 2209 year: 2009 ident: R31-20250608 article-title: Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand publication-title: N Engl J Med doi: 10.1056/NEJMoa0908492 – volume: 397 start-page: 7 year: 2010 ident: R40-20250608 article-title: Loss of HIV-specific memory B-cells as a potential mechanism for the dysfunction of the humoral immune response against HIV publication-title: Virology doi: 10.1016/j.virol.2009.11.003 – volume: 496 start-page: 469 year: 2013 ident: R9-20250608 article-title: Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus publication-title: Nature doi: 10.1038/nature12053 – volume: 36 start-page: 7700 year: 2018 ident: R30-20250608 article-title: V4 region of the HIV-1 envelope gene mediates immune escape and may not promote the development of broadly neutralizing antibodies publication-title: Vaccine doi: 10.1016/j.vaccine.2018.10.084 – volume: 183 start-page: 2708 year: 2009 ident: R41-20250608 article-title: HIV-1 envelope induces memory B cell responses that correlate with plasma antibody levels after envelope gp120 protein vaccination or HIV-1 infection publication-title: J Immunol doi: 10.4049/jimmunol.0901068 – volume: 100 start-page: 511 year: 2019 ident: R18-20250608 article-title: Increased predominance of HIV-1 CRF01_AE and its recombinants in the Philippines publication-title: J Gen Virol doi: 10.1099/jgv.0.001198 – volume: 21 start-page: 586 year: 2005 ident: R20-20250608 article-title: Sequences of clustered epitopes in Gag and Nef potentially presented by predominant class I human leukocyte antigen (HLA) alleles A and B expressed by human immunodeficiency virus type 1 (HIV-1)-infected patients in Vietnam publication-title: AIDS Res Hum Retroviruses doi: 10.1089/aid.2005.21.586 – volume: 67 start-page: 6642 year: 1993 ident: R50-20250608 article-title: A conserved neutralizing epitope on gp41 of human immunodeficiency virus type 1 publication-title: J Virol doi: 10.1128/jvi.67.11.6642-6647.1993 – volume: 158 start-page: 481 year: 2014 ident: R12-20250608 article-title: Cooperation of B cell lineages in induction of HIV-1-broadly neutralizing antibodies publication-title: Cell doi: 10.1016/j.cell.2014.06.022 – volume: 98 start-page: 10362 year: 2001 ident: R7-20250608 article-title: HIV-1 induces phenotypic and functional perturbations of B cells in chronically infected individuals publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.181347898 – volume: 200 start-page: 587 year: 2004 ident: R39-20250608 article-title: Decreased survival of B cells of HIV-viremic patients mediated by altered expression of receptors of the TNF superfamily publication-title: J Exp Med doi: 10.1084/jem.20032236 – volume: 393 start-page: 648 year: 1998 ident: R5-20250608 article-title: Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody publication-title: Nature doi: 10.1038/31405 – volume: 14 start-page: 1687 year: 1998 ident: R15-20250608 article-title: Short communication: HIV type 1 subtypes in malaysia, determined with serologic assays: 1992–1996 publication-title: AIDS Res Hum Retroviruses doi: 10.1089/aid.1998.14.1687 – volume: 34 start-page: 1603 year: 2020 ident: R55-20250608 article-title: Higher frequencies of functional HIV-envelope-specific memory B cells are associated with nonprogressive HIV infection in Indian population publication-title: AIDS doi: 10.1097/QAD.0000000000002620 – volume: 30 start-page: 681 year: 2016 ident: R22-20250608 article-title: A strong association of human leukocyte antigen-associated Pol and Gag mutations with clinical parameters in HIV-1 subtype A/E infection publication-title: AIDS doi: 10.1097/QAD.0000000000000969 – volume: 11 start-page: 615 year: 2005 ident: R58-20250608 article-title: Delay of HIV-1 rebound after cessation of antiretroviral therapy through passive transfer of human neutralizing antibodies publication-title: Nat Med doi: 10.1038/nm1244 – volume: 343 start-page: 65 year: 2009 ident: R47-20250608 article-title: A method for identification of HIV gp140 binding memory B cells in human blood publication-title: J Immunol Methods doi: 10.1016/j.jim.2008.11.012 – volume: 15 start-page: 160 year: 2015 ident: R33-20250608 article-title: The generation of antibody-secreting plasma cells publication-title: Nat Rev Immunol doi: 10.1038/nri3795 – volume: 329 start-page: 811 year: 2010 ident: R35-20250608 article-title: Structural basis for broad and potent neutralization of HIV-1 by antibody VRC01 publication-title: Science doi: 10.1126/science.1192819 – volume: 108 start-page: 1580 year: 2006 ident: R38-20250608 article-title: Loss of memory B cells impairs maintenance of long-term serologic memory during HIV-1 infection publication-title: Blood doi: 10.1182/blood-2005-11-013383 – volume: 5 start-page: e8805 year: 2010 ident: R49-20250608 article-title: Analysis of memory B cell responses and isolation of novel monoclonal antibodies with neutralizing breadth from HIV-1-infected individuals publication-title: PLoS One doi: 10.1371/journal.pone.0008805 – volume: 10 start-page: 62648 year: 2021 ident: R57-20250608 article-title: Distinct clonal evolution of B-cells in HIV controllers with neutralizing antibody breadth publication-title: eLife doi: 10.7554/eLife.62648 – volume: 10 start-page: e0114947 year: 2015 ident: R32-20250608 article-title: Recalibration of the limiting antigen avidity EIA to determine mean duration of recent infection in divergent HIV-1 subtypes publication-title: PLoS One doi: 10.1371/journal.pone.0114947 – volume: 18 start-page: 346 year: 2016 ident: R25-20250608 article-title: Neutralization breadth and potency of serum derived from recently human immunodeficiency virus type 1-infected Thai individuals publication-title: Microbes Infect doi: 10.1016/j.micinf.2015.12.009 – volume: 301 start-page: 1374 year: 2003 ident: R46-20250608 article-title: Predominant autoantibody production by early human B cell precursors publication-title: Science doi: 10.1126/science.1086907 – volume: 83 start-page: 188 year: 2009 ident: R54-20250608 article-title: Frequency and phenotype of human immunodeficiency virus envelope-specific B cells from patients with broadly cross-neutralizing antibodies publication-title: J Virol doi: 10.1128/JVI.01583-08 – volume: 11 start-page: 32 year: 2014 ident: R24-20250608 article-title: Impact of amino acid substitutions in the V2 and C2 regions of human immunodeficiency virus type 1 CRF01_AE envelope glycoprotein gp120 on viral neutralization susceptibility to broadly neutralizing antibodies specific for the CD4 binding site publication-title: Retrovirology doi: 10.1186/1742-4690-11-32 – volume: 163 start-page: 3303 year: 2018 ident: R26-20250608 article-title: Evaluation of susceptibility of HIV-1 CRF01_AE variants to neutralization by a panel of broadly neutralizing antibodies publication-title: Arch Virol doi: 10.1007/s00705-018-4011-7 – volume: 32 start-page: 851 year: 2016 ident: R17-20250608 article-title: Nationwide trends in molecular epidemiology of HIV-1 in China publication-title: AIDS Res Hum Retroviruses doi: 10.1089/aid.2016.0029 |
SSID | ssj0005088 |
Score | 2.4036748 |
Snippet | In HIV type 1 (HIV-1) infection, virus-specific B-cell and neutralizing antibody (NAb) responses are impaired but exert selective pressure on target viral... |
SourceID | proquest pubmed crossref wolterskluwer |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 1629 |
SubjectTerms | Antibodies, Neutralizing Cell Differentiation HIV Antibodies HIV Infections HIV-1 - genetics Humans |
Title | Association of envelope-specific B-cell differentiation and viral selective pressure signatures in HIV-1 CRF01_AE infection |
URI | https://ovidsp.ovid.com/ovidweb.cgi?T=JS&NEWS=n&CSC=Y&PAGE=fulltext&D=ovft&AN=00002030-202210010-00003 https://www.ncbi.nlm.nih.gov/pubmed/35848590 https://www.proquest.com/docview/2691460730 |
Volume | 36 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ba9swFBahg7Exyu5Ld0GDvQVtdmRb0WPWC8lGBlvb0TcjyXIbGuzRJJR2v2r_cEeSL2qSsXWBmESRHFvns3SO9J1zEHoXxowmmoVEaarBQAljwmXIiaKg_WeaMimNg_PkSzI6jj6dxCedzi-PtbRcyPfqeqNfyf9IFcpArsZL9haSbU4KBfAZ5AtHkDAc_0nGXt8apU8XlgCkiXGfNBSg3kdiFuabLCiLqq5ZLDfk3llvbtPgGPaQJcSa3QTD6LDRPi1TdjT-TsLe7reDIEyH-w13q_CV2uF479BPDcLbYW1p8QDz4anJEArvpbcRcja9FpfCeQzNxXnZNrsQmS0_PJue6qsSara7F27FdnLVGwl_yQKs3Zr8Vi1ZbAg9YZcspjPDC_JGwH7CCehPgT9cu3gpNSz73uAbJtUN6uqrC6m1Nkm44MNfh3sueGX1otQ5Pq-E3w7cZm1AzI2YgFXWEd_El73TB8vEWvHjzy2rKLCpTpsrr701Ofuw6Q9vakNrJs599OCyNKyJ-bl1mvBUn6OHaLuyWfDQAfAR6ujiMbo7qVgZT9BPD4e4zPEaDrHDIV7BIQYcYotD3OAQ1zjELQ7xtMAWh7jGIW5w-BQdH-wf7Y5IldSDqAimD8IzxmTCmYLRn0ulEg1aaB7kkVShYCzUMma5ipga9Fkijb2cxSKJeJILFmua0WdoqygL_QJhsETkgAqR5ZpHIfT4gOlM59BcDjSosl1E685NVRXx3iRemaU18wJEkq6KpItI0-qHi_jyl_pva7mlMDSb7hSFLpfzFK4I9BAzh3bRcyfQ5owUFP9BzOEXckPCqXN_Tv8Eu51b1n-J7rVP4Cu0tbhY6tegRi_kGwvc30_evPE |
linkProvider | Flying Publisher |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Association+of+envelope-specific+B-cell+differentiation+and+viral+selective+pressure+signatures+in+HIV-1+CRF01_AE+infection&rft.jtitle=AIDS+%28London%29&rft.au=Hau%2C+Trang+Thi+Thu&rft.au=Nishizawa%2C+Masako&rft.au=Harada%2C+Shigeyoshi&rft.au=Phan%2C+My+Ha&rft.date=2022-10-01&rft.pub=Lippincott+Williams+%26+Wilkins&rft.issn=0269-9370&rft.volume=36&rft.issue=12&rft.spage=1629&rft.epage=1641&rft_id=info:doi/10.1097%2FQAD.0000000000003323&rft.externalDocID=00002030-202210010-00003 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0269-9370&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0269-9370&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0269-9370&client=summon |